Richard Peters, President & CEO, Director at Merrimack Pharmaceuticals, holds ― shares in Merrimack Pharmaceuticals (Ticker: MACK), holds 2.07K shares in Aprea Therapeutics (Ticker: APRE), holds 88.10K shares in Kineta (Ticker: KANT). Most recently, Richard Peters ― shares of Merrimack Pharmaceuticals on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Richard Peters?
The percentage of profitable transactions made by Richard Peters is 67%.
What is the average return per transaction made by Richard Peters?
The average return per transaction made by Richard Peters is 5.00%.
What stocks does Richard Peters hold?
Richard Peters holds: MACK, APRE, KANT stocks.
What was Richard Peters’s latest transaction?
Richard Peters latest transaction was an Uninformative Buy of ―.
What was Richard Peters's most profitable transaction?
Richard Peters’s most profitable transaction was an Informative Sell of KANT stock on July 6, 2022. The return on the trade was 24.60%.
What is Richard Peters's role in Merrimack Pharmaceuticals?
Richard Peters's role in Merrimack Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.